IL6 and neoplasm: IL-17 pathway activation promotes differentiation and recruitment of Th17 cells, thereby sustaining chronic inflammation and perpetuating pro-inflammatory cytokine networks (including IL-6, IL-8, GM-CSF), which create a tumour-supportive microenvironment (117, 118).